Caffeine, creatine, GRIN2A and Parkinson’s disease progression

Caffeine is neuroprotective in animal models of PD and caffeine intake is inversely associated with the risk of Parkinson’s disease (PD). This association may be influenced by the genotype of GRIN2A, which encodes an NMDA-glutamate-receptor subunit. In two placebo-controlled studies, we detected no...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Neurol Sci
Egile Nagusiak: Simon, David K., Wu, Cai, Tilley, Barbara C., Lohmann, Katja, Klein, Christine, Payami, Haydeh, Wills, Anne-Marie, Aminoff, Michael J., Bainbridge, Jacquelyn, Dewey, Richard, Hauser, Robert A., Schaake, Susen, Schneider, Jay S., Sharma, Saloni, Singer, Carlos, Tanner, Caroline M., Truong, Daniel, Wei, Peng, Wong, Pei Shieen, Yang, Tianzhong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5386398/
https://ncbi.nlm.nih.gov/pubmed/28320167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2017.02.032
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak